| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Unidad de Neuroendocrinología Molecular, Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, E-28871 Alcalá de Henares-Madrid, Spain
Address all correspondence and requests for reprints to: M. Pilar López-Ruiz, Unidad de Neuroendocrinología Molecular, Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, E-28871 Alcalá de Henares-Madrid, Spain. E-mail: bqplr{at}bioqui.alcala.es
Previous results from our group have indicated that arachidonic acid
decrease cAMP production through a modification of heterotrimeric G
proteins. In the present study, we have characterized the high affinity
GTPase activity present in Leydig cell membranes and its regulation by
fatty acids. The high-affinity GTPase activity, measured as
[
32P] GTP hydrolysis rate, was both time and protein
concentration dependent. Arachidonic acid elicited a dose-dependent
inhibition of enzyme activity with an IC50 = 26.7
± 1.1 µM. The existence of only two double bonds in
linoleic acid is reflected by a decrease in its inhibitory activity
(IC50 = 34 ± 2.3 µM). Saturated
fatty acids showed no effect at this level. The kinetic analysis as
interpreted by Lineweaver-Burk plots, indicated that 50
µM arachidonic acid had no effect on the apparent
affinity for GTP, but resulted in a 40% decreases in the maximal
velocity of the reaction. Arachidonic acid modulation of GTPase
activity was not attenuated by blocking eicosanoid metabolism with
inhibitors of 5'-lipoxygenase, cyclooxygenase, or epoxygenase P-450.
The addition of arachidonic acid to pertussis toxin-treated membranes
had no effect on the enzyme activity, indicating that arachidonic acid
does not modify the GTPase activity present in G
s
protein. However, ADP-ribosylation with cholera toxin followed by
arachidonic acid treatment led to a further 40% inhibition when
compared with cholera toxin treatment alone. These results allowed us
to postulate that arachidonic acid inhibits the GTPase activity of
Gi protein family. To further analyze the mechanism
of arachidonic acid inhibition of GTPase activity, the effect of
arachidonic acid on the [35S]GTP
S binding was studied.
No effect of this fatty acid on GTP binding was found. Combining our
previous results with those found here, we can conclude that
arachidonic acid maintains Gi proteins in their active
state, which in turn inhibit adenylate cyclase and results in decrease
cAMP levels.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |